NICOLE CHUM: Open Payments
NPI 1699402016 · PERU, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,428 in 137 payments from 16 companies in 2025. Trend: 2023 $1,500 · 2024 $2,084 · 2025 $2,428
Food & beverage: $2,087Education: $341
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $305 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $284 |
| Lilly USA, LLC | 15 | $262 |
| ABBVIE INC. | 17 | $246 |
| Novartis Pharmaceuticals Corporation | 10 | $186 |
| UCB, Inc. | 11 | $186 |
| Organon LLC | 18 | $185 |
| SANOFI-AVENTIS U.S. LLC | 2 | $180 |
| Regeneron Healthcare Solutions, Inc. | 8 | $156 |
| Smith+Nephew, Inc. | 2 | $116 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, Bimzelx, EBGLYSS, TALTZ, GRAFIX PL.
Industry payments across IL — which companies pay providers there.
